{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:33:36Z","timestamp":1794443616080,"version":"4.9.1"},"publisher-location":"Vienna","reference-count":80,"publisher":"Springer Vienna","isbn-type":[{"value":"9783709115107","type":"print"},{"value":"9783709115114","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-3-7091-1511-4_18","type":"book-chapter","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T01:43:12Z","timestamp":1365212592000},"page":"355-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sphingolipids and Inflammatory Diseases of the Skin"],"prefix":"10.1007","author":[{"given":"Burkhard","family":"Kleuser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Japtok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"issue":"10","key":"18_CR00181","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/jid.2012.174","volume":"132","author":"S Aho","year":"2012","unstructured":"Aho S, Harding CR, Lee JM, Meldrum H, Bosko CA (2012) Regulatory role for the profilaggrin N-terminal domain in epidermal homeostasis. J Invest Dermatol 132(10):2376\u20132385","journal-title":"J Invest Dermatol."},{"key":"18_CR00182","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1523-1747.2001.01283.x","volume":"116","author":"F Alessandrini","year":"2001","unstructured":"Alessandrini F, Stachowitz S, Ring J, Behrendt H (2001) The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. J Invest Dermatol 116:394\u2013400","journal-title":"J Invest Dermatol"},{"key":"18_CR00183","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1600-0625.2011.01346.x","volume":"20","author":"T Andoh","year":"2011","unstructured":"Andoh T, Haza S, Saito A, Kuraishi Y (2011) Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions. Exp Dermatol 20:894\u2013898","journal-title":"Exp Dermatol"},{"key":"18_CR00184","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1523-1747.2002.01846.x","volume":"119","author":"J Arikawa","year":"2002","unstructured":"Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G (2002) Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 119:433\u2013439","journal-title":"J Invest Dermatol"},{"key":"18_CR00185","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/jid.2010.252","volume":"131","author":"W Baumer","year":"2011","unstructured":"Baumer W, Rossbach K, Mischke R, Reines I, Langbein-Detsch I, Luth A, Kleuser B (2011) Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. J Invest Dermatol 131:266\u2013268","journal-title":"J Invest Dermatol"},{"key":"18_CR00186","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1523-1747.2000.00846.x","volume":"114","author":"M Behne","year":"2000","unstructured":"Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM (2000) Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 114:185\u2013192","journal-title":"J Invest Dermatol"},{"key":"18_CR00187","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1600-0625.1998.tb00334.x","volume":"7","author":"M Bektas","year":"1998","unstructured":"Bektas M, Dullin Y, Wieder T, Kolter T, Sandhoff K, Brossmer R, Ihrig P, Orfanos CE, Geilen CC (1998) Induction of apoptosis by synthetic ceramide analogues in the human keratinocyte cell line HaCaT. Exp Dermatol 7:342\u2013349","journal-title":"Exp Dermatol"},{"key":"18_CR00188","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11154-011-9194-0","volume":"13","author":"DD Bikle","year":"2012","unstructured":"Bikle DD (2012) Vitamin D and the skin: physiology and pathophysiology. Rev Endocr Metab Disord 13:3\u201319","journal-title":"Rev Endocr Metab Disord"},{"key":"18_CR00189","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cellsig.2010.11.012","volume":"23","author":"F Bornancin","year":"2011","unstructured":"Bornancin F (2011) Ceramide kinase: the first decade. Cell Signal 23:999\u20131008","journal-title":"Cell Signal"},{"key":"18_CR001810","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bcp.2010.03.009","volume":"80","author":"H Choi","year":"2010","unstructured":"Choi H, Kim S, Kim HJ, Kim KM, Lee CH, Shin JH, Noh M (2010) Sphingosylphosphorylcholine down-regulates filaggrin gene transcription through NOX5-based NADPH oxidase and cyclooxygenase-2 in human keratinocytes. Biochem Pharmacol 80:95\u2013103","journal-title":"Biochem Pharmacol"},{"key":"18_CR001811","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0463.2011.02832.x","volume":"120","author":"AD Christensen","year":"2012","unstructured":"Christensen AD, Haase C (2012) Immunological mechanisms of contact hypersensitivity in mice. APMIS 120:1\u201327","journal-title":"APMIS"},{"key":"18_CR001812","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/jid.2011.435","volume":"132","author":"A De Benedetto","year":"2012","unstructured":"De Benedetto A, Kubo A, Beck LA (2012) Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol 132:949\u2013963","journal-title":"J Invest Dermatol"},{"key":"18_CR001813","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1096\/fj.15.3.807","volume":"15","author":"HP Deigner","year":"2001","unstructured":"Deigner HP, Claus R, Bonaterra GA, Gehrke C, Bibak N, Blaess M, Cantz M, Metz J, Kinscherf R (2001) Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. FASEB J 15:807\u2013814","journal-title":"FASEB J"},{"key":"18_CR001814","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Di Cesare","year":"2009","unstructured":"Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23\/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339\u20131350","journal-title":"J Invest Dermatol"},{"key":"18_CR001815","doi-asserted-by":"publisher","first-page":"11038","DOI":"10.1074\/jbc.274.16.11038","volume":"274","author":"T Doering","year":"1999","unstructured":"Doering T, Holleran WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K (1999) Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem 274:11038\u201311045","journal-title":"J Biol Chem"},{"key":"18_CR001816","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0014-5793(95)01421-7","volume":"378","author":"CC Geilen","year":"1996","unstructured":"Geilen CC, Bektas M, Wieder T, Orfanos CE (1996) The vitamin D3 analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytes. FEBS Lett 378:88\u201392","journal-title":"FEBS Lett"},{"key":"18_CR001817","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1074\/jbc.272.14.8997","volume":"272","author":"CC Geilen","year":"1997","unstructured":"Geilen CC, Bektas M, Wieder T, Kodelja V, Goerdt S, Orfanos CE (1997) 1alpha,25-dihydroxyvitamin D3 induces sphingomyelin hydrolysis in HaCaT cells via tumor necrosis factor alpha. J Biol Chem 272:8997\u20139001","journal-title":"J Biol Chem"},{"key":"18_CR001818","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1046\/j.1523-1747.2002.01836.x","volume":"119","author":"S Hamanaka","year":"2002","unstructured":"Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, Uchida Y (2002) Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 119:416\u2013423","journal-title":"J Invest Dermatol"},{"key":"18_CR001819","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0005-2760(85)90009-8","volume":"834","author":"HS Hansen","year":"1985","unstructured":"Hansen HS, Jensen B (1985) Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water permeability barrier. Evidence from feeding studies with oleate, linoleate, arachidonate, columbinate and alpha-linolenate. Biochim Biophys Acta 834:357\u2013363","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 3","key":"18_CR001820","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1042\/0264-6021:3500747","volume":"350","author":"K Higuchi","year":"2000","unstructured":"Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G (2000) The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 350(Pt 3):747\u2013756","journal-title":"Biochem J"},{"key":"18_CR001821","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/S0022-2275(20)32209-4","volume":"42","author":"K Higuchi","year":"2001","unstructured":"Higuchi K, Kawashima M, Takagi Y, Kondo H, Yada Y, Ichikawa Y, Imokawa G (2001) Sphingosylphosphorylcholine is an activator of transglutaminase activity in human keratinocytes. J Lipid Res 42:1562\u20131570","journal-title":"J Lipid Res"},{"key":"18_CR001822","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1172\/JCI117160","volume":"93","author":"WM Holleran","year":"1994","unstructured":"Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E (1994) Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 93:1756\u20131764","journal-title":"J Clin Invest"},{"key":"18_CR001823","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1016\/j.febslet.2006.08.039","volume":"580","author":"WM Holleran","year":"2006","unstructured":"Holleran WM, Takagi Y, Uchida Y (2006) Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 580:5456\u20135466","journal-title":"FEBS Lett"},{"key":"18_CR001824","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/1523-1747.ep12470233","volume":"96","author":"G Imokawa","year":"1991","unstructured":"Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A (1991) Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 96:523\u2013526","journal-title":"J Invest Dermatol"},{"key":"18_CR001825","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1523-1747.1999.00462.x","volume":"112","author":"G Imokawa","year":"1999","unstructured":"Imokawa G, Takagi Y, Higuchi K, Kondo H, Yada Y (1999) Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. J Invest Dermatol 112:91\u201396","journal-title":"J Invest Dermatol"},{"key":"18_CR001826","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/01.LAB.0000059931.66821.92","volume":"83","author":"M Ishibashi","year":"2003","unstructured":"Ishibashi M, Arikawa J, Okamoto R, Kawashima M, Takagi Y, Ohguchi K, Imokawa G (2003) Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis. Lab Invest 83:397\u2013408","journal-title":"Lab Invest"},{"key":"18_CR001827","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/hmg\/ddr494","volume":"21","author":"R Jennemann","year":"2012","unstructured":"Jennemann R et al (2012) Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum Mol Genet 21:586\u2013608","journal-title":"Hum Mol Genet"},{"key":"18_CR001828","first-page":"689","volume":"144","author":"JM Jensen","year":"2009","unstructured":"Jensen JM, Proksch E (2009) The skin\u2019s barrier. G Ital Dermatol Venereol 144:689\u2013700","journal-title":"G Ital Dermatol Venereol"},{"key":"18_CR001829","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.0022-202X.2004.22621.x","volume":"122","author":"JM Jensen","year":"2004","unstructured":"Jensen JM, Folster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, Schutze S, Proksch E (2004) Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 122:1423\u20131431","journal-title":"J Invest Dermatol"},{"key":"18_CR001830","doi-asserted-by":"publisher","first-page":"18942","DOI":"10.1074\/jbc.M109.006973","volume":"284","author":"YJ Jiang","year":"2009","unstructured":"Jiang YJ, Uchida Y, Lu B, Kim P, Mao C, Akiyama M, Elias PM, Holleran WM, Grunfeld C, Feingold KR (2009) Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor delta in human keratinocytes. J Biol Chem 284:18942\u201318952","journal-title":"J Biol Chem"},{"key":"18_CR001831","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2340\/0001555574341343","volume":"74","author":"K Jin","year":"1994","unstructured":"Jin K, Higaki Y, Takagi Y, Higuchi K, Yada Y, Kawashima M, Imokawa G (1994) Analysis of beta-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol 74:337\u2013340","journal-title":"Acta Derm Venereol"},{"key":"18_CR001832","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1046\/j.1523-1747.1998.00137.x","volume":"110","author":"EM Jung","year":"1998","unstructured":"Jung EM, Griner RD, Mann-Blakeney R, Bollag WB (1998) A potential role for ceramide in the regulation of mouse epidermal keratinocyte proliferation and differentiation. J Invest Dermatol 110:318\u2013323","journal-title":"J Invest Dermatol"},{"key":"18_CR001833","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.it.2010.08.006","volume":"31","author":"DH Kaplan","year":"2010","unstructured":"Kaplan DH (2010) In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol 31:446\u2013451","journal-title":"Trends Immunol"},{"key":"18_CR001834","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejphar.2008.01.005","volume":"583","author":"HJ Kim","year":"2008","unstructured":"Kim HJ, Kim H, Han ES, Park SM, Koh JY, Kim KM, Noh MS, Kim JJ, Lee CH (2008) Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632. Eur J Pharmacol 583:92\u201396","journal-title":"Eur J Pharmacol"},{"key":"18_CR001835","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1172\/JCI57416","volume":"122","author":"A Kubo","year":"2012","unstructured":"Kubo A, Nagao K, Amagai M (2012) Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 122:440\u2013447","journal-title":"J Clin Invest"},{"key":"18_CR001836","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-2275(20)38006-8","volume":"24","author":"MA Lampe","year":"1983","unstructured":"Lampe MA, Williams ML, Elias PM (1983) Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 24:131\u2013140","journal-title":"J Lipid Res"},{"key":"18_CR001837","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","volume":"371","author":"CL Leonardi","year":"2008","unstructured":"Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, Li S, Dooley LT, Gordon KB (2008) Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371:1665\u20131674","journal-title":"Lancet"},{"key":"18_CR001838","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, Braun D, Banerjee S (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 366:1190\u20131199","journal-title":"N Engl J Med"},{"key":"18_CR001839","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.jid.5701207","volume":"128","author":"K Lichte","year":"2008","unstructured":"Lichte K, Rossi R, Danneberg K, ter Braak M, Kurschner U, Jakobs KH, Kleuser B, Meyer zu Heringdorf D (2008) Lysophospholipid receptor-mediated calcium signaling in human keratinocytes. J Invest Dermatol 128:1487\u20131498","journal-title":"J Invest Dermatol"},{"key":"18_CR001840","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1096\/fj.07-092981","volume":"22","author":"YY Liu","year":"2008","unstructured":"Liu YY et al (2008) A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J 22:2541\u20132551","journal-title":"FASEB J"},{"key":"18_CR001841","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866\u2013873","journal-title":"Nature"},{"key":"18_CR001842","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22:50\u201360","journal-title":"Trends Cell Biol"},{"key":"18_CR001843","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1523-1747.2002.01833.x","volume":"119","author":"O Macheleidt","year":"2002","unstructured":"Macheleidt O, Kaiser HW, Sandhoff K (2002) Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 119:166\u2013173","journal-title":"J Invest Dermatol"},{"key":"18_CR001844","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1046\/j.0022-202x.2001.01496.x","volume":"117","author":"M Manggau","year":"2001","unstructured":"Manggau M, Kim DS, Ruwisch L, Vogler R, Korting HC, Schafer-Korting M, Kleuser B (2001) 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol 117:1241\u20131249","journal-title":"J Invest Dermatol"},{"key":"18_CR001845","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/jid.2009.98","volume":"129","author":"R Marsella","year":"2009","unstructured":"Marsella R, Girolomoni G (2009) Canine models of atopic dermatitis: a useful tool with untapped potential. J Invest Dermatol 129:2351\u20132357","journal-title":"J Invest Dermatol"},{"key":"18_CR001846","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1194\/jlr.M800014-JLR200","volume":"49","author":"Y Masukawa","year":"2008","unstructured":"Masukawa Y et al (2008) Characterization of overall ceramide species in human stratum corneum. J Lipid Res 49:1466\u20131476","journal-title":"J Lipid Res"},{"key":"18_CR001847","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cellsig.2006.09.004","volume":"19","author":"D Mechtcheriakova","year":"2007","unstructured":"Mechtcheriakova D et al (2007) Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal 19:748\u2013760","journal-title":"Cell Signal"},{"key":"18_CR001848","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/1523-1747.ep12355263","volume":"86","author":"GK Menon","year":"1986","unstructured":"Menon GK, Grayson S, Elias PM (1986) Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis. J Invest Dermatol 86:591\u2013597","journal-title":"J Invest Dermatol"},{"issue":"Suppl 2","key":"18_CR001849","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.2007.08264.x","volume":"157","author":"T Meyer","year":"2007","unstructured":"Meyer T, Stockfleth E, Christophers E (2007) Immune response profiles in human skin. Br J Dermatol 157(Suppl 2):1\u20137","journal-title":"Br J Dermatol"},{"key":"18_CR001850","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1042\/BJ20060379","volume":"398","author":"Y Mizutani","year":"2006","unstructured":"Mizutani Y, Kihara A, Igarashi Y (2006) LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity. Biochem J 398:531\u2013538","journal-title":"Biochem J"},{"key":"18_CR001851","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1194\/jlr.M800158-JLR200","volume":"49","author":"Y Mizutani","year":"2008","unstructured":"Mizutani Y, Kihara A, Chiba H, Tojo H, Igarashi Y (2008) 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. J Lipid Res 49:2356\u20132364","journal-title":"J Lipid Res"},{"key":"18_CR001852","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0925-4439(93)90135-N","volume":"1182","author":"S Motta","year":"1993","unstructured":"Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R (1993) Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1182:147\u2013151","journal-title":"Biochim Biophys Acta"},{"key":"18_CR001853","first-page":"131","volume":"186","author":"S Motta","year":"1994","unstructured":"Motta S, Sesana S, Monti M, Giuliani A, Caputo R (1994a) Interlamellar lipid differences between normal and psoriatic stratum corneum. Acta Derm Venereol Suppl (Stockh) 186:131\u2013132","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"18_CR001854","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/archderm.1994.01690040056007","volume":"130","author":"S Motta","year":"1994","unstructured":"Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R (1994b) Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 130:452\u2013456","journal-title":"Arch Dermatol"},{"key":"18_CR001855","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/BF00371745","volume":"287","author":"S Motta","year":"1995","unstructured":"Motta S, Sesana S, Ghidoni R, Monti M (1995) Content of the different lipid classes in psoriatic scale. Arch Dermatol Res 287:691\u2013694","journal-title":"Arch Dermatol Res"},{"key":"18_CR001856","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12016-007-0039-2","volume":"33","author":"BJ Nickoloff","year":"2007","unstructured":"Nickoloff BJ, Qin JZ, Nestle FO (2007) Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol 33:45\u201356","journal-title":"Clin Rev Allergy Immunol"},{"key":"18_CR001857","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/CDLI.6.1.101-104.1999","volume":"6","author":"Y Ohnishi","year":"1999","unstructured":"Ohnishi Y, Okino N, Ito M, Imayama S (1999) Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immunol 6:101\u2013104","journal-title":"Clin Diagn Lab Immunol"},{"key":"18_CR001858","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1016\/S0021-9258(19)47268-2","volume":"264","author":"T Okazaki","year":"1989","unstructured":"Okazaki T, Bell RM, Hannun YA (1989) Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 264:19076\u201319080","journal-title":"J Biol Chem"},{"key":"18_CR001859","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/bse0500265","volume":"50","author":"F Quazi","year":"2011","unstructured":"Quazi F, Molday RS (2011) Lipid transport by mammalian ABC proteins. Essays Biochem 50:265\u2013290","journal-title":"Essays Biochem"},{"key":"18_CR001860","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.4049\/jimmunol.174.5.2778","volume":"174","author":"HH Radeke","year":"2005","unstructured":"Radeke HH, von Wenckstern H, Stoidtner K, Sauer B, Hammer S, Kleuser B (2005) Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol 174:2778\u20132786","journal-title":"J Immunol"},{"key":"18_CR001861","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/archdermatol.2011.9","volume":"147","author":"S Rajpopat","year":"2011","unstructured":"Rajpopat S et al (2011) Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases. Arch Dermatol 147:681\u2013686","journal-title":"Arch Dermatol"},{"key":"18_CR001862","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/jid.2008.454","volume":"129","author":"I Reines","year":"2009","unstructured":"Reines I, Kietzmann M, Mischke R, Tschernig T, Luth A, Kleuser B, Baumer W (2009) Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J Invest Dermatol 129:1954\u20131962","journal-title":"J Invest Dermatol"},{"key":"18_CR001863","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-0625.2011.01395.x","volume":"21","author":"L Rose","year":"2012","unstructured":"Rose L, Schneider C, Stock C, Zollner TM, Docke WD (2012) Extended DNFB-induced contact hypersensitivity models display characteristics of chronic inflammatory dermatoses. Exp Dermatol 21:25\u201331","journal-title":"Exp Dermatol"},{"key":"18_CR001864","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1084\/jem.184.6.2411","volume":"184","author":"F Sallusto","year":"1996","unstructured":"Sallusto F, Nicolo C, De Maria R, Corinti S, Testi R (1996) Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med 184:2411\u20132416","journal-title":"J Exp Med"},{"key":"18_CR001865","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00216-012-5843-8","volume":"403","author":"DR Santinha","year":"2012","unstructured":"Santinha DR, Marques DR, Maciel EA, Simoes CS, Rosa S, Neves BM, Macedo B, Domingues P, Cruz MT, Domingues MR (2012) Profiling changes triggered during maturation of dendritic cells: a lipidomic approach. Anal Bioanal Chem 403:457\u2013471","journal-title":"Anal Bioanal Chem"},{"key":"18_CR001866","doi-asserted-by":"publisher","first-page":"38471","DOI":"10.1074\/jbc.M313557200","volume":"279","author":"B Sauer","year":"2004","unstructured":"Sauer B, Vogler R, von Wenckstern H, Fujii M, Anzano MB, Glick AB, Schafer-Korting M, Roberts AB, Kleuser B (2004) Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J Biol Chem 279:38471\u201338479","journal-title":"J Biol Chem"},{"key":"18_CR001867","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.molimm.2011.02.007","volume":"48","author":"M Schroder","year":"2011","unstructured":"Schroder M, Richter C, Juan MH, Maltusch K, Giegold O, Quintini G, Pfeilschifter JM, Huwiler A, Radeke HH (2011) The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen. Mol Immunol 48:1139\u20131148","journal-title":"Mol Immunol"},{"key":"18_CR001868","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1096\/fj.10-179028","volume":"25","author":"T Schulze","year":"2011","unstructured":"Schulze T, Golfier S, Tabeling C, Rabel K, Graler MH, Witzenrath M, Lipp M (2011) Sphingosine-1-phospate receptor 4 (S1P(4)) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J 25:4024\u20134036","journal-title":"FASEB J"},{"key":"18_CR001869","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/sj.jid.5701259","volume":"128","author":"M Schuppel","year":"2008","unstructured":"Schuppel M, Kurschner U, Kleuser U, Schafer-Korting M, Kleuser B (2008) Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. J Invest Dermatol 128:1747\u20131756","journal-title":"J Invest Dermatol"},{"key":"18_CR001870","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/sj.jid.5700234","volume":"126","author":"EY Seo","year":"2006","unstructured":"Seo EY, Park GT, Lee KM, Kim JA, Lee JH, Yang JM (2006) Identification of the target genes of atopic dermatitis by real-time PCR. J Invest Dermatol 126:1187\u20131189","journal-title":"J Invest Dermatol"},{"issue":"Suppl 1","key":"18_CR001871","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1002\/eji.200737400","volume":"37","author":"RM Steinman","year":"2007","unstructured":"Steinman RM (2007) Dendritic cells: understanding immunogenicity. Eur J Immunol 37(Suppl 1):S53\u2013S60","journal-title":"Eur J Immunol"},{"key":"18_CR001872","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","volume":"106","author":"RJ Tamargo","year":"2012","unstructured":"Tamargo RJ, Velayati A, Goldin E, Sidransky E (2012) The role of saposin C in Gaucher disease. Mol Genet Metab 106:257\u2013263","journal-title":"Mol Genet Metab"},{"key":"18_CR001873","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1111\/j.1742-4658.2008.06527.x","volume":"275","author":"K Tsuji","year":"2008","unstructured":"Tsuji K, Mitsutake S, Yokose U, Sugiura M, Kohama T, Igarashi Y (2008) Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes. FEBS J 275:3815\u20133826","journal-title":"FEBS J"},{"key":"18_CR001874","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdermsci.2008.01.002","volume":"51","author":"Y Uchida","year":"2008","unstructured":"Uchida Y, Holleran WM (2008) Omega-O-acylceramide, a lipid essential for mammalian survival. J Dermatol Sci 51:77\u201387","journal-title":"J Dermatol Sci"},{"key":"18_CR001875","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0022-2275(20)32369-5","volume":"41","author":"Y Uchida","year":"2000","unstructured":"Uchida Y, Hara M, Nishio H, Sidransky E, Inoue S, Otsuka F, Suzuki A, Elias PM, Holleran WM, Hamanaka S (2000) Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 41:2071\u20132082","journal-title":"J Lipid Res"},{"key":"18_CR001876","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1046\/j.1523-1747.2003.12096.x","volume":"120","author":"R Vogler","year":"2003","unstructured":"Vogler R, Sauer B, Kim DS, Schafer-Korting M, Kleuser B (2003) Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J Invest Dermatol 120:693\u2013700","journal-title":"J Invest Dermatol"},{"key":"18_CR001877","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/BF00402228","volume":"286","author":"H Wakita","year":"1994","unstructured":"Wakita H, Tokura Y, Yagi H, Nishimura K, Furukawa F, Takigawa M (1994) Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine. Arch Dermatol Res 286:350\u2013354","journal-title":"Arch Dermatol Res"},{"key":"18_CR001878","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1523-1747.1998.00120.x","volume":"110","author":"H Wakita","year":"1998","unstructured":"Wakita H, Matsushita K, Nishimura K, Tokura Y, Furukawa F, Takigawa M (1998) Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. J Invest Dermatol 110:253\u2013258","journal-title":"J Invest Dermatol"},{"key":"18_CR001879","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jdermsci.2009.03.005","volume":"55","author":"SH Wood","year":"2009","unstructured":"Wood SH, Clements DN, Ollier WE, Nuttall T, McEwan NA, Carter SD (2009) Gene expression in canine atopic dermatitis and correlation with clinical severity scores. J Dermatol Sci 55:27\u201333","journal-title":"J Dermatol Sci"},{"key":"18_CR001880","doi-asserted-by":"publisher","first-page":"36624","DOI":"10.1074\/jbc.M807377200","volume":"283","author":"Y Zuo","year":"2008","unstructured":"Zuo Y, Zhuang DZ, Han R, Isaac G, Tobin JJ, McKee M, Welti R, Brissette JL, Fitzgerald ML, Freeman MW (2008) ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters. J Biol Chem 283:36624\u201336635","journal-title":"J Biol Chem"}],"container-title":["Handbook of Experimental Pharmacology","Sphingolipids in Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-1511-4_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T07:56:10Z","timestamp":1715154970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-7091-1511-4_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9783709115107","9783709115114"],"references-count":80,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-1511-4_18","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-7091-1511-4","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"7 March 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}